Remicade 100 MG vials
Ended Awarded
- Contract number
- SPE2DR26F9CN1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,097
Award facts
- Contract value 100% obligated
- $14,097.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on November 20, 2025, for the supply of Remicade 100 mg vials with a ceiling value of $14,097.07. This award is not set-aside and utilizes firm fixed-price pricing under a competitive delivery order contract. The performance location is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is one of the nation's leading pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic areas. As a major prime vendor in the DLA's pharmaceutical supply network, AmerisourceBergen fulfills orders for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current Remicade order is one of numerous delivery orders issued against the company's blanket pharmaceutical contract with DLA.
Quick answers
Who was awarded contract SPE2DR26F9CN1?
SPE2DR26F9CN1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F9CN1 worth?
The government has obligated $14,097 on SPE2DR26F9CN1.
Is contract SPE2DR26F9CN1 an order under another contract?
Yes. SPE2DR26F9CN1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9CN1 competed?
The extent of competition for SPE2DR26F9CN1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award